Adenocarcinoma of the Rectum [clinicaltrials_resource:2b84f4137189028e3ae226feeb641ad2]
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer [clinicaltrials:NCT00003799]Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00003873]SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer [clinicaltrials:NCT00005818]Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum [clinicaltrials:NCT00006094]Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer [clinicaltrials:NCT00023933]Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated [clinicaltrials:NCT00025337]Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver [clinicaltrials:NCT00026234]Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer [clinicaltrials:NCT00028496]Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer [clinicaltrials:NCT00032110]Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer [clinicaltrials:NCT00052559]Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer [clinicaltrials:NCT00052585]Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer [clinicaltrials:NCT00070122]clinicaltrials:NCT00100841Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009) [clinicaltrials:NCT00303628]Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer [clinicaltrials:NCT00307736]clinicaltrials:NCT00321685Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer [clinicaltrials:NCT00397384]clinicaltrials:NCT00397878Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery [clinicaltrials:NCT00433576]clinicaltrials:NCT00551421clinicaltrials:NCT00707889clinicaltrials:NCT00942266Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks [clinicaltrials:NCT01037049]PD 0332991 in Treating Patients With Refractory Solid Tumors [clinicaltrials:NCT01037790]Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer [clinicaltrials:NCT01270438]Midostaurin (PKC412) for Locally Advanced Rectal Cancer [clinicaltrials:NCT01282502]Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer [clinicaltrials:NCT01294826]Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer [clinicaltrials:NCT01340755]clinicaltrials:NCT02046538clinicaltrials:NCT02425683
condition [clinicaltrials_vocabulary:condition]
Adenocarcinoma of the Rectum [clinicaltrials_resource:2b84f4137189028e3ae226feeb641ad2]
Bio2RDF identifier
2b84f4137189028e3ae226feeb641ad2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2b84f4137189028e3ae226feeb641ad2
identifier
clinicaltrials_resource:2b84f4137189028e3ae226feeb641ad2
title
Adenocarcinoma of the Rectum
@en
label
Adenocarcinoma of the Rectum [clinicaltrials_resource:2b84f4137189028e3ae226feeb641ad2]
@en